Review Article
TAVR: A Review of Current Practices and Considerations in Low-Risk Patients
Table 2
Comparison of factors used in SAVR and TAVR risk scores [
28,
30].
| | STS score | EuroSCORE II | TAVI2SCORe |
| Peripheral vascular disease | Yes | Yes | No | Renal failure | Yes | Yes | Yes | Dialysis | Yes | No | No | Neurological dysfunction | Yes | Yes | No | Diabetes | Yes | No | No | Atrial fibrillation | Yes | No | No | COPD | Yes | Yes | No | NYHA class | Yes | Yes | No | LVEF | Yes | Yes | Yes | CAD | Yes | No | No | Pulmonary hypertension | No | Yes | No | Others | | | Porcelain thoracic aorta, recent myocardial infarction (within 90 days), anemia (<10 g/dl), male sex, critical aortic valve stenosis (mean gradient ≥70 mmHg), age (>85 years) |
|
|
SAVR = surgical aortic valve replacement; TAVR = transcatheter aortic valve replacement; COPD = chronic obstructive pulmonary disease; NYHA = New York Heart Association Class; LVEF = left ventricular ejection fraction; CAD = coronary artery disease.
|